sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
CBIO
Updated 10/6/2026, 8:56 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| CBIO CRESCENT BIOPHARMA, INC. | Sale | $4,296 | Lynch Ryan See Remarks | 240 sh | at $17.90 | Filed Sep 18, 4:03 PM ET | Filing | |
| CBIO CRESCENT BIOPHARMA, INC. | Sale | $11,778 | Pinkas Jan Chief Scientific Officer | 658 sh | at $17.90 | Filed Sep 18, 4:03 PM ET | Filing | |
| CBIO CRESCENT BIOPHARMA, INC. | Sale | $11,152 | Im Ellie Eunkyung Chief Medical Officer | 623 sh | at $17.90 | Filed Sep 18, 4:02 PM ET | Filing | |
| CBIO CRESCENT BIOPHARMA, INC. | Sale | $10,167 | Scalzo Richard William Chief Financial Officer | 568 sh | at $17.90 | Filed Sep 18, 4:02 PM ET | Filing | |
| CBIO CRESCENT BIOPHARMA, INC. | Sale | $11,098 | Bispham Barbara Harlin See Remarks | 620 sh | at $17.90 | Filed Sep 18, 4:02 PM ET | Filing | |
| CBIO CRESCENT BIOPHARMA, INC. | Sale | $159,775 | Brumm Joshua T Chief Executive Officer, Director | 9,447 sh | at $16.91 | Filed Sep 18, 4:02 PM ET | Filing | |
| CBIO CRESCENT BIOPHARMA, INC. | Sale | $77,235 | McNeill Jonathan President and COO | 4,570 sh | at $16.90 | Filed Sep 18, 4:01 PM ET | Filing | |
| CBIO CRESCENT BIOPHARMA, INC. | Buy | $12,375,025 | Fairmount Funds Management LLC Director, 10% owner and 3 others | 853,450 sh | at $14.50 | Filed Jul 20, 5:30 PM ET | Filing |